Nuvectis Pharma, Inc. (NVCT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.57M | -38.9% |
| 2024 | -$19.85M | +13.3% |
| 2023 | -$22.90M | -19.0% |
| 2022 | -$19.23M | -49.2% |
| 2021 | -$12.89M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.57M | -38.9% |
| 2024 | -$19.85M | +13.3% |
| 2023 | -$22.90M | -19.0% |
| 2022 | -$19.23M | -49.2% |
| 2021 | -$12.89M | — |